Atara Biotherapeutics Inc ATRA
NASDAQ · United States · Health Technology
$9.20+0.70 (+8.24%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.32 | -0.32 | -1.6% | $630.00K | +14.5% | -4.8%$8.94→$8.51 |
| Q1 2026 | 2026-05-12 | -0.29 | — | — | — | — | +19.4%$8.78→$10.48 |
| Q4 2025 | 2026-03-16 | -0.35 | -0.10 | -250.0% | — | — | -19.5%$6.50→$5.23 |
| Q3 2025 | 2025-11-12 | -0.32 | -0.83 | +61.4% | — | — | +6.6%$12.56→$13.39 |
| Q4 2024 | 2025-03-07 | -1.19 | -3.49 | +65.9% | — | — | — |
| Q2 2024 | 2024-08-12 | -3.10 | -2.24 | -38.4% | — | — | — |
| Q4 2023 | 2024-03-28 | -14.00 | -12.05 | -16.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.